- Home
- TOVX vs SPRC Comparison
TOVX vs SPRC Comparison
Compare TOVX & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- SPRC
- Stock Information
- Founded
- TOVX 2001
- SPRC 2004
- Country
- TOVX United States
- SPRC Israel
- Employees
- TOVX N/A
- SPRC N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- TOVX Health Care
- SPRC Health Care
- Exchange
- TOVX Nasdaq
- SPRC Nasdaq
- Market Cap
- TOVX 3.8M
- SPRC 3.4M
- IPO Year
- TOVX 2006
- SPRC N/A
- Fundamental
- Price
- TOVX $0.43
- SPRC $0.30
- Analyst Decision
- TOVX Hold
- SPRC
- Analyst Count
- TOVX 1
- SPRC 0
- Target Price
- TOVX N/A
- SPRC N/A
- AVG Volume (30 Days)
- TOVX 1.6M
- SPRC 196.1K
- Earning Date
- TOVX 08-12-2025
- SPRC 02-15-2025
- Dividend Yield
- TOVX N/A
- SPRC N/A
- EPS Growth
- TOVX N/A
- SPRC N/A
- EPS
- TOVX N/A
- SPRC N/A
- Revenue
- TOVX N/A
- SPRC $1,306,000.00
- Revenue This Year
- TOVX N/A
- SPRC N/A
- Revenue Next Year
- TOVX N/A
- SPRC N/A
- P/E Ratio
- TOVX N/A
- SPRC N/A
- Revenue Growth
- TOVX N/A
- SPRC N/A
- 52 Week Low
- TOVX $0.40
- SPRC $0.20
- 52 Week High
- TOVX $7.37
- SPRC $1.79
- Technical
- Relative Strength Index (RSI)
- TOVX 33.63
- SPRC 49.11
- Support Level
- TOVX $0.43
- SPRC $0.29
- Resistance Level
- TOVX $0.46
- SPRC $0.34
- Average True Range (ATR)
- TOVX 0.04
- SPRC 0.02
- MACD
- TOVX 0.02
- SPRC -0.00
- Stochastic Oscillator
- TOVX 15.54
- SPRC 33.33
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.